Where does Evolva SA rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Evolva SA ranks #5,669 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Evolva SA hold?

Evolva SA holds 60 US utility patents granted between 2015 and 2024, spanning 20 technology areas.

What is Evolva SA's Innovation Score?

Evolva SA has an Innovation Score of 43.3 out of 100 (top 29% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Evolva SA's patent grant rate increasing or decreasing?

Evolva SA's recent grant velocity is +0% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Evolva SA's patents?

Evolva SA's patents average 18.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Evolva SA patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Evolva SA

Q: What technology areas does Evolva SA focus on?

Evolva SA's top technology area is C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture) with 52 patents, ranking #25 of 1,268 assignees active in that subclass. Grants appear in 20 CPC subclasses total.

USPTO PatentsView assignee record - 60 granted patents across 20 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Evolva ranks #5,669 of 49,997 tracked US assignees by granted-patent volume, with 60 patents across 20 technology areas.

#5,669
of 49,997 US assignees by volume: Top 29%
by Innovation Score (43.3/100): 18.8
avg claims per patent: +0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5669 · Foreign Corporation #5,669 · 60 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL

GRANTS-SMALL 60 grants
UPPER-Q #5,669/49,997
PHOTO-FINISH Dow Technology…
CPC-FOCUS C12P · 20 areas
INNOV-PAR 43.3/100
CLAIMS-RICH 18.8 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-FLAT +0% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Dow Technology Investments LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Evolva’s 43.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 14.2 pts (33%) Velocity 1.9 pts (4%) Breadth 15.8 pts (37%) Claim depth 11.3 pts (26%)

Qualcomm Incorporated · highest

85
Prothena Biosciences · near

43
Evolva · this assignee

43
Hiperbaric · near

43
Loop Commerce · near

43
GE Medical Systems… · near

43
3D Lighting… · lowest

7

What this shows Evolva's Innovation Score is 43.3/100 (top 29% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Evolva?

Each dot is one of Evolva’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Evolva’s own 18.8 claims/patent is ABOVE the 10.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Evolva vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Evolva's grants concentrate

Evolva SA is a focused PatentsView assignee: 20 CPC subclasses with 86.7% of grants classified under C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture). Peak complete grant year is 2021 (11 grants) versus a trough of 1 in 2024. By volume, Evolva sits between Dow Technology Investments LLC and Generac Power Systems, Inc..

Evolva's three-year grant acceleration

From 2019–2021 to 2022–2024, Evolva SA moved from 31 to 9 grants (0.29x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Dow Technology In…

60
Dyaco Internation…

60
East China Normal…

60
Everich AND Tomic…

60
Everlast Climbing…

60
F S Korea Industr…

60
Guangdong Midea K…

60
Generac Power Sys…

60
Evolva ◀

60

What this shows Evolva holds 60 patents at rank #5,667, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Evolva

By rank, the assignees closest to #5,667 in granted patent volume.

Leaders in C12P (Fermentation OR Enzyme-using Processes TO Synthesise A De…)

Other assignees with the most granted patents in Evolva's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Evolva, neither rank-band nor same-CPC leaders (those blocks stay above). In C12P (Fermentation OR Enzyme-using Processes TO Synthesise A De…), Evolva ranks #25 of 1,268 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (43 here).

Loop Commerce, Inc. 43 Hiperbaric, S.A. 43 GE Medical Systems Global Technology Company, LLC 43 Prothena Biosciences Limited 43

Similar claim depth

Nearest assignees by average claims per patent (18.8 here).

L3 Technologies, Inc. 18.8 avg NIO USA, Inc. 18.8 avg Hill-Rom Services, Inc. 18.8 avg Verily Life Sciences LLC 18.8 avg

Evolva's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

43 Top 29% higher than 71% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Evolva SA patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	5.0%
2016	3	5.0%
2017	7	11.7%
2018	7	11.7%
2019	10	16.7%
2020	10	16.7%
2021	11	18.3%
2022	4	6.7%
2023	4	6.7%
2024	1	1.7%

Which technologies does Evolva SA patent most?

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 52

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 48

C12Y - Enzymes 37

A23L - Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof 21

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 13

C07K - Peptides 9

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 7

A23V - Indexing Scheme Relating TO Foods, Foodstuffs OR Non-alcoholic Beverages AND Lactic OR Propionic Acid Bacteria Used IN Foodstuffs OR Food Preparation 6

C07D - Heterocyclic Compounds 5

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 5

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 5

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 3

Y02A - Technologies FOR Adaptation TO Climate Change 3

C07C - Acyclic OR Carbocyclic Compounds 2

A23B - Preservation OF Foods, Foodstuffs OR Non-alcoholic BEVERAGES; Chemical Ripening OF Fruit OR Vegetables 2

Top 15 of 20 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Evolva SA's patent record in context - here's where to go next.

Evolva SA's lead technology class is C12P (Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture), 86.7% of its portfolio - see every assignee active in that class. Explore C12P
Ranked #5,669 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Evolva SA against Dow Technology Investments LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 43.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.